US3326213A - Therapeutic dressing material and method of using the same - Google Patents
Therapeutic dressing material and method of using the same Download PDFInfo
- Publication number
- US3326213A US3326213A US381562A US38156264A US3326213A US 3326213 A US3326213 A US 3326213A US 381562 A US381562 A US 381562A US 38156264 A US38156264 A US 38156264A US 3326213 A US3326213 A US 3326213A
- Authority
- US
- United States
- Prior art keywords
- leaf
- mil
- gold
- dressing material
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 8
- 239000000463 material Substances 0.000 title description 9
- 230000001225 therapeutic effect Effects 0.000 title description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 27
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 206010052428 Wound Diseases 0.000 description 12
- 239000010931 gold Substances 0.000 description 11
- 229910052737 gold Inorganic materials 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 9
- 210000001631 vena cava inferior Anatomy 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 210000000709 aorta Anatomy 0.000 description 4
- 210000000702 aorta abdominal Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 239000011888 foil Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 241000282836 Camelus dromedarius Species 0.000 description 2
- 229920001875 Ebonite Polymers 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241001269524 Dura Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000219823 Medicago Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010051077 Post procedural haemorrhage Diseases 0.000 description 1
- 208000037486 Postoperative Hemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 210000000576 arachnoid Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 229940105631 nembutal Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000505 parietal peritoneum Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 210000002796 renal vein Anatomy 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/06—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings
- A61F13/064—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for feet
- A61F13/069—Decubitus ulcer bandages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00157—Wound bandages for burns or skin transplants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00519—Plasters use for treating burn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00936—Plasters containing means metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/51—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
- A61F2013/51095—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers being metallic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
Definitions
- This invention relates to a novel medical and surgical dressing material and method of using the same for the treatment of damaged mammalian tissues.
- It can also be used to seal holes in the skull and other bones, to cover wounds of the brain to protect the sites of anastomosis of nerve trunks and of blood vessels, and to seal holes and openings in the membranes of the brain and spinal cord, such as the dura and the arachnoid. It is also useful in the treatment of disorders of the skin such as chronic ulcerations, acne and in the treatment of wounds of various sizes.
- an electrical charge is conferred on the leaf, for example, by stroking a camel hair or other mammalian hair brush against a hard rubber comb and then touching the leaf with the charged brush.
- the gold leaf clings to the brush and can be directly implanted from the brush upon the tissue surface or area to be treated.
- Electrically charged beaten gold in foil or leaf form displays a unique ability to cling to the body tissues and remains closely adhered to any irregular contours of the surface on which it has been placed. Since fine gold is almost inert chemically adverse tissue reactions are almost nil.
- fine gold is used herein to designate gold of about 23 karats or more of fineness or purity.
- the aorta was wounded in situ and in others the aorta was held up from its bed by a surgical clamp and then wounded. In most of the animals only one aortic Wound was made. In the others, two aortic wounds were made. The inferior vena cava was wounded in a similar fashion. In many cases, larger wounds of the vena cava were made by passing the cutting edged needle into the lumen of the vain obliquely and then removing it with a tearing motion.
- the opening in the vessel was then covered with a charged piece of gold leaf about 1 cm. square.
- a charged piece of gold leaf about 1 cm. square.
- two or three pieces of leaf were necessary to produce complete hemostasis.
- five or six pieces of leaf, laid one on top of the other were necessary for absolute hemostasis.
- Hemorrhage from wounds of the inferior vena cava could be arrested using only one or two pieces of charged gold leaf.
- both with aortic and caval wounds the field had to be kept clear of pools of blood, otherwise the leaf could not gain firm contact for closure. If the field was flooded with blood, the piece of gold floated away from the implantation site.
- the sites of gold implantation on the aorta, inferior vena cava, and the sites of capillary bleeding on the rabbit ears were examined at various intervals after surgery. In no case, including animals under observation for as long as 45 days after injury, did postoperative hemorrhage occur from any of the vascular wound sites. In all cases the gold leaf was found to be securely in place with no gross signs of adverse tissue to the metal.
- the abdominal aorta and the inferior vena cava were removed en bloc from each animal for pathologic study.
- the arterial blood pressures have been measured in all of the common laboratory animals and in all of them the systolic and diastolic levels approach that noted in the normal human.
- the pressures measured in the inferior vena cava range between 4 and 5 mm. mercury.
- the diameter of the rabbit abdominal aorta is about 1.75 mm. and the inferior vena cava about 3.0 mm.
- the wounds made in the aorta in the experiments described above were about 0.5 mm. or about 25% of the diameter of the vessel.
- the wounds made in the vena cava were at least 0.5 mm. or 33 of the vessels diameter.
- a therapeutic dressing material comprising beaten fine gold leaf having an electrical charge to adapt it to cling to body tissue and having a thickness in the range of from about 0.0003 mil to about 0.1 mil.
- a therapeutic dressing material comprising beaten fine gold leaf having an electrical charge to adapt it to 3 cling to body tissue and having a thickness in the range of from about 0.001 mil to about 0.01 mil.
- a method of treating damaged mammalian tissue which comprises electrically charging beaten fine gold leaf having a thickness of from about 0.0003 mil to about 0.1 mil and applying the electrically charged gold leaf to the damaged tissue.
- a therapeutic dressing material comprising fine gold leaf having a thickness in the range of from about 0.0003 mil to about 0.1 mil and a backing for said fine gold.
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
Description
United States Patent 3,326,213 THERAPEUTIC DRESSING MATERIAL AND METHOD OF USING THE SAME John P. Gallagher, 2415 Foxhall Road, NW.,
Washington, D.C. 20007 No Drawing. Filed July 9, 1964, Ser. No. 381,562 6 Claims. (Cl. 128-456) This invention relates to a novel medical and surgical dressing material and method of using the same for the treatment of damaged mammalian tissues.
I have found that fine gold, in leaf or foil form when electrostatically charged, has a number of beneficial effects in surgery and medicine. It is highly effective as a hemostat-ic material in arresting hemorrhage from arterial, venous and capillary sources. It is useful in the treatment of burned surfaces on the body both fresh and otherwise. It may be used to close openings in hollow and solid organs of the gastrointestinal and genito-urinary tracts, such as the stomach, intestines, bile duct, liver, kidney, pelvis of the kidney, ureter and bladder. It can also be used to seal holes in the skull and other bones, to cover wounds of the brain to protect the sites of anastomosis of nerve trunks and of blood vessels, and to seal holes and openings in the membranes of the brain and spinal cord, such as the dura and the arachnoid. It is also useful in the treatment of disorders of the skin such as chronic ulcerations, acne and in the treatment of wounds of various sizes.
In the application of the gold leaf an electrical charge is conferred on the leaf, for example, by stroking a camel hair or other mammalian hair brush against a hard rubber comb and then touching the leaf with the charged brush. The gold leaf clings to the brush and can be directly implanted from the brush upon the tissue surface or area to be treated. When the charged leaf is touched to the surface it is released immediately from the brush and clings securely to the tissue surface. Electrically charged beaten gold in foil or leaf form displays a unique ability to cling to the body tissues and remains closely adhered to any irregular contours of the surface on which it has been placed. Since fine gold is almost inert chemically adverse tissue reactions are almost nil.
The term fine gold is used herein to designate gold of about 23 karats or more of fineness or purity.
Although fine gold leaf in the form typically supplied in booklets for decorative gilding and having a thickness of the order of 0.0003 to 0.0004 mil can be used for the purposes of the invention, leaf of somewhat greater thicknesses in the range of about 0.001 mil to about 0.01 mil is preferred and for some applications leaf or foil of a thickness up to about 0.1 mil are useful.
While solid sheets of gold leaf are useful in most surgical or medical applications, it may if desired be applied in perforated form or with a cloth or plastic or an adhesive backing. The backing may be medicated.
Experimental tests on animals have established the usefulness of the material and methods described above. Effective procedures will be described by way of example with reference to a series of tests with rabbits which animal has systemic arterial blood pressures approximating those found in man.
Commercially available gold leaf of 23 karat gold as supplied in booklets for decorative purposes were used in the tests and the pieces of leaf were charged as used by means of sterilized camel hair brushes and a hard rubber com'b as described above.
Rabbits weighing between 1.5 kg. and 2.0 kg. were utilized. In all cases the abdominal aorta and the inferior vena cava were exposed through a long midline abdominal incision under intravenous barbiturate (Nembutal) 3 ,325,213 Patented June 20, 1967 anesthesia. Direct access to both vessels was made by incision of the posterior parietal peritoneum from a point just above the renal vein and artery and extending down to the iliacs. The abdominal aorta was wounded by piercing it with a straight cutting edged surgical needle. The induced wound was always great enough to produce jets of arterial 'blood from two inches to twenty-four inches in height. In some animals the aorta was wounded in situ and in others the aorta was held up from its bed by a surgical clamp and then wounded. In most of the animals only one aortic Wound was made. In the others, two aortic wounds were made. The inferior vena cava was wounded in a similar fashion. In many cases, larger wounds of the vena cava were made by passing the cutting edged needle into the lumen of the vain obliquely and then removing it with a tearing motion.
After making the aortic wound the opening in the vessel was then covered with a charged piece of gold leaf about 1 cm. square. In the case of small jets of blood, two or three pieces of leaf were necessary to produce complete hemostasis. With large jets, five or six pieces of leaf, laid one on top of the other were necessary for absolute hemostasis. Hemorrhage from wounds of the inferior vena cava could be arrested using only one or two pieces of charged gold leaf. In all cases, both with aortic and caval wounds the field had to be kept clear of pools of blood, otherwise the leaf could not gain firm contact for closure. If the field was flooded with blood, the piece of gold floated away from the implantation site. However, it -was found that the golf leaf adheres well to moist surfaces and that it is not necessary to completely dry the target area. After hemostasis had been achieved in each large vessel, the abdominal wall was closed in routine fashion with continuous black silk sutures'for the deep and superficial layers.
The efficiency of charged gold leaf in controlling capillary hemorrhage was tested in a number of these animals. The cars of several rabbits were closely shaved and the shaven surfaces were abraded with a carpenters rasp. After brisk capillary bleeding was started, the charged leaf was then applied to the raw surfaces for hemostasis. All of the animals used in this series received 200,000 units of penicillin at the end of surgery.
The sites of gold implantation on the aorta, inferior vena cava, and the sites of capillary bleeding on the rabbit ears were examined at various intervals after surgery. In no case, including animals under observation for as long as 45 days after injury, did postoperative hemorrhage occur from any of the vascular wound sites. In all cases the gold leaf was found to be securely in place with no gross signs of adverse tissue to the metal. The abdominal aorta and the inferior vena cava were removed en bloc from each animal for pathologic study.
The arterial blood pressures have been measured in all of the common laboratory animals and in all of them the systolic and diastolic levels approach that noted in the normal human. The pressures measured in the inferior vena cava range between 4 and 5 mm. mercury. The diameter of the rabbit abdominal aorta is about 1.75 mm. and the inferior vena cava about 3.0 mm. The wounds made in the aorta in the experiments described above were about 0.5 mm. or about 25% of the diameter of the vessel. The wounds made in the vena cava were at least 0.5 mm. or 33 of the vessels diameter.
I claim:
1. A therapeutic dressing material comprising beaten fine gold leaf having an electrical charge to adapt it to cling to body tissue and having a thickness in the range of from about 0.0003 mil to about 0.1 mil.
2. A therapeutic dressing material comprising beaten fine gold leaf having an electrical charge to adapt it to 3 cling to body tissue and having a thickness in the range of from about 0.001 mil to about 0.01 mil.
3. A method of treating damaged mammalian tissue which comprises electrically charging beaten fine gold leaf having a thickness of from about 0.0003 mil to about 0.1 mil and applying the electrically charged gold leaf to the damaged tissue.
4. A method of arresting hemorrhage in mammals which comprises electrically charging beaten fine gold leaf having a thickness of from about 0.0003 mil to about 0.1 mil and applying the electrically charged gold leaf to the hemorrhaging tissue.
5. A therapeutic dressing material comprising fine gold leaf having a thickness in the range of from about 0.0003 mil to about 0.1 mil and a backing for said fine gold.
6. The invention defined in claim 5 wherein the backing comprises plastic and the therapeutic dressing material is perforated.
References Cited UNITED STATES PATENTS 6/1965 Baum 3215 OTHER REFERENCES Gold Prevents Adhesion, Science News Letter, October 3, 1964.
Medics Back to Gold Treatment for Arthritis, Science News Letter, February 21, 1959, page 119; copy in 167- 68D.
15 ADELE M. EAGER, Primary Examiner.
Claims (1)
- 3. A METHOD OF TREATING DAMAGED MAMMALIAN TISSUE WHICH COMPRISES ELECTRICALLY CHARGING BEATEN FINE GOLD LEAF HAVING A THICKNESS OF FROM ABOUT 0.0003 MIL TO ABOUT 0.1 MIL AND APPLYING THE ELECTRICALLY CHARGED GOLD LEAF TO THE DAMAGED TISSUE.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US381562A US3326213A (en) | 1964-07-09 | 1964-07-09 | Therapeutic dressing material and method of using the same |
GB24735/65A GB1115633A (en) | 1964-07-09 | 1965-06-11 | Therapeutic dressing material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US381562A US3326213A (en) | 1964-07-09 | 1964-07-09 | Therapeutic dressing material and method of using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
US3326213A true US3326213A (en) | 1967-06-20 |
Family
ID=23505509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US381562A Expired - Lifetime US3326213A (en) | 1964-07-09 | 1964-07-09 | Therapeutic dressing material and method of using the same |
Country Status (2)
Country | Link |
---|---|
US (1) | US3326213A (en) |
GB (1) | GB1115633A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3420233A (en) * | 1965-11-24 | 1969-01-07 | Naomi M Kanof | Method and therapeutic device for stimulating vascular activity,production of granulation tissue,and epithelialization in a cutaneous region |
US4411648A (en) * | 1981-06-11 | 1983-10-25 | Board Of Regents, The University Of Texas System | Iontophoretic catheter device |
US4755384A (en) * | 1982-07-16 | 1988-07-05 | Kozponti Valto- es Hitelbank RT, Innovacious Alap | Externally applied antispasmatic products |
US20040049145A1 (en) * | 1997-09-22 | 2004-03-11 | Flick A. Bart | Multilayer conductive appliance having wound healing and analgesic properties |
US20040143289A1 (en) * | 2003-01-22 | 2004-07-22 | Zahler Byron Gale | Combined hemostasis pressure applicator and dressing sheet |
US20050244484A1 (en) * | 1997-09-22 | 2005-11-03 | Flick A B | Multilayer conductive appliance having wound healing and analgesic properties |
US7005556B1 (en) | 1995-09-05 | 2006-02-28 | Argentum Medical | Multilayer wound dressing |
US7214847B1 (en) | 1997-09-22 | 2007-05-08 | Argentum Medical, L.L.C. | Multilayer conductive appliance having wound healing and analgesic properties |
US8118791B2 (en) | 1995-09-05 | 2012-02-21 | Argentum Medical, Llc | Medical device |
US8449514B2 (en) | 1997-09-22 | 2013-05-28 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8700150D0 (en) * | 1987-01-06 | 1987-02-11 | Martin I F | Wound dressings |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3191303A (en) * | 1962-05-21 | 1965-06-29 | Baum Lloyd | Tooth filling material |
-
1964
- 1964-07-09 US US381562A patent/US3326213A/en not_active Expired - Lifetime
-
1965
- 1965-06-11 GB GB24735/65A patent/GB1115633A/en not_active Expired
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3191303A (en) * | 1962-05-21 | 1965-06-29 | Baum Lloyd | Tooth filling material |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3420233A (en) * | 1965-11-24 | 1969-01-07 | Naomi M Kanof | Method and therapeutic device for stimulating vascular activity,production of granulation tissue,and epithelialization in a cutaneous region |
US4411648A (en) * | 1981-06-11 | 1983-10-25 | Board Of Regents, The University Of Texas System | Iontophoretic catheter device |
US4755384A (en) * | 1982-07-16 | 1988-07-05 | Kozponti Valto- es Hitelbank RT, Innovacious Alap | Externally applied antispasmatic products |
US20080114279A1 (en) * | 1995-09-05 | 2008-05-15 | Argentum Medical, Llc | Multilayer laminate wound dressing |
US8801681B2 (en) | 1995-09-05 | 2014-08-12 | Argentum Medical, Llc | Medical device |
US8293964B2 (en) | 1995-09-05 | 2012-10-23 | Argentum Medical, Llc | Multilayer laminate wound dressing |
US8283513B2 (en) | 1995-09-05 | 2012-10-09 | Argentum Medical, Llc | Multilayer wound dressing |
US7005556B1 (en) | 1995-09-05 | 2006-02-28 | Argentum Medical | Multilayer wound dressing |
US8118791B2 (en) | 1995-09-05 | 2012-02-21 | Argentum Medical, Llc | Medical device |
US6861570B1 (en) | 1997-09-22 | 2005-03-01 | A. Bart Flick | Multilayer conductive appliance having wound healing and analgesic properties |
US7291762B2 (en) | 1997-09-22 | 2007-11-06 | Argentum International, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
US7230153B2 (en) | 1997-09-22 | 2007-06-12 | Argentum International, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
EP2316524A1 (en) | 1997-09-22 | 2011-05-04 | Argentum International, LLC | Multilayer conductive appliance having wound healing and analgesic properties |
US7989674B2 (en) | 1997-09-22 | 2011-08-02 | Argentum Medical, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
US8093444B2 (en) | 1997-09-22 | 2012-01-10 | Argentum Medical, Llc | Multilayer conductive appliance having wound healing and analgesic properties |
US7214847B1 (en) | 1997-09-22 | 2007-05-08 | Argentum Medical, L.L.C. | Multilayer conductive appliance having wound healing and analgesic properties |
US20050244484A1 (en) * | 1997-09-22 | 2005-11-03 | Flick A B | Multilayer conductive appliance having wound healing and analgesic properties |
US8449514B2 (en) | 1997-09-22 | 2013-05-28 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
US8455710B2 (en) | 1997-09-22 | 2013-06-04 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
US20040049145A1 (en) * | 1997-09-22 | 2004-03-11 | Flick A. Bart | Multilayer conductive appliance having wound healing and analgesic properties |
US20040143289A1 (en) * | 2003-01-22 | 2004-07-22 | Zahler Byron Gale | Combined hemostasis pressure applicator and dressing sheet |
Also Published As
Publication number | Publication date |
---|---|
GB1115633A (en) | 1968-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3326213A (en) | Therapeutic dressing material and method of using the same | |
DE60111386T2 (en) | SYSTEM FOR IMPROVED CHEMICAL REMOVAL OF NECROTIC TISSUE | |
Mohs | Chemosurgery: a microscopically controlled method of cancer excision | |
US5019034A (en) | Control of transport of molecules across tissue using electroporation | |
US4554317A (en) | Synthetic wound covering | |
JPH02503270A (en) | bandage | |
DE69132692T2 (en) | Wound dressing and catheter holder made of a polyurethane-biopolymer composite material | |
Jenkins et al. | Studies on the use of gelatin sponge or foam as an hemostatic agent in experimental liver resections and injuries to large veins | |
GB1598817A (en) | Wound repair | |
SE9804183L (en) | Biocompatible adhesive | |
Prudden et al. | The clinical acceleration of healing with a cartilage preparation: a controlled study | |
RU2108079C1 (en) | Method for treating burn wounds | |
Hawkins et al. | Percutaneous placement of Hickman catheters for prolonged venous access | |
Kinkead et al. | A ganglion of the temporomandibular joint presenting as a parotid tumor | |
Leonard | THE APPLICATION OF THE ROENTGEN RAYS TO MEDICAL DIAGNOSIS. | |
RU2655832C2 (en) | Method of surgical treatment of patients with total scar facial deformities | |
US20040002772A1 (en) | Tissue equivalents with perforations for improved integration to host tissues and methods for producing perforated tissue equivalents | |
Lockhart et al. | A Comparison of Polyethylene and Tantalum for Cranioplasty: A Preliminary Report | |
EP3104815B1 (en) | Bioresonant dressing for rapid healing of wounds, process for obtaining the same and use thereof | |
Simon et al. | A new technique for securing a chest tube | |
RU2752747C1 (en) | Method for treating trophic skin disorders in patients with severe brain damage | |
JENNEY | Clot fixation in the open method of free skin grafting | |
RU2132646C1 (en) | Method for performing laparoscopic cholecystectomy | |
RU2337654C1 (en) | Method for sealing of sclera rupture and/or wound, located on eyeball rear side | |
SU1718868A1 (en) | Method for treating calcaneodynia |